
Potential of Sivelestat for Pulmonary Arterial Hypertension Treatment: Network Pharmacology-Based Target Identification ...
Introduction PAH is a severe condition characterized by elevated blood pressure in the pulmonary arteries, leading to significant morbidity and mortality.1 Epidemiological studies estimate that the prevalence of PAH is approximately 15–50 cases per million …